620 related articles for article (PubMed ID: 19494489)
1. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
Sparo MD; Jones DG; Sánchez Bruni SF
Chemotherapy; 2009; 55(4):270-7. PubMed ID: 19494489
[TBL] [Abstract][Full Text] [Related]
2. In vitro efficacy of the novel peptide CECT7121 against bacteria isolated from mastitic dairy cattle.
Sparo MD; Jones DG; Sánchez Bruni SF
Lett Appl Microbiol; 2009 Feb; 48(2):187-92. PubMed ID: 19141040
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal Activity and Synergy Studies of Peptide AP-CECT7121 Against Multi-resistant Bacteria Isolated from Human and Animal Soft Tissue Infections.
Delpech G; Bistoletti M; Ceci M; Lissarrague S; Bruni SS; Sparo M
Probiotics Antimicrob Proteins; 2017 Sep; 9(3):355-362. PubMed ID: 28573492
[TBL] [Abstract][Full Text] [Related]
4. Patterns of isolation of common gram positive bacterial pathogens and their susceptibilities to antimicrobial agents in Jimma Hospital.
Gebreselassie S
Ethiop Med J; 2002 Apr; 40(2):115-27. PubMed ID: 12240573
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the antimicrobial resistance patterns of gram-positive cocci isolated from community-private and university-affiliated hospitals from Puerto Rico.
Vázquez GJ; Robledo IE; Arroyo A; Nadal E; Rodríguez R; Bermudez M; Colón M
P R Health Sci J; 2003 Jun; 22(2):131-6. PubMed ID: 12866136
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative.
Draghi DC; Benton BM; Krause KM; Thornsberry C; Pillar C; Sahm DF
J Antimicrob Chemother; 2008 Jul; 62(1):116-21. PubMed ID: 18424792
[TBL] [Abstract][Full Text] [Related]
8. In vitro ciprofloxacin resistance patterns of gram-positive bacteria isolated from clinical specimens in a teaching hospital in Saudi Arabia.
Akhtar N; Alzahrani A; Obeid Oel-T; Dassal D
J Ayub Med Coll Abbottabad; 2009; 21(3):54-6. PubMed ID: 20929013
[TBL] [Abstract][Full Text] [Related]
9. Everninomicin, a new oligosaccharide antibiotic: its antimicrobial activity, post-antibiotic effect and synergistic bactericidal activity.
Nakashio S; Iwasawa H; Dun FY; Kanemitsu K; Shimada J
Drugs Exp Clin Res; 1995; 21(1):7-16. PubMed ID: 7796712
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of selected plant species from "the Argentine Puna" against sensitive and multi-resistant bacteria.
Zampini IC; Cuello S; Alberto MR; Ordoñez RM; D' Almeida R; Solorzano E; Isla MI
J Ethnopharmacol; 2009 Jul; 124(3):499-505. PubMed ID: 19467313
[TBL] [Abstract][Full Text] [Related]
11. Potent antimicrobial activity of 3-(4,5-diaryl-1H-imidazol-2-yl)-1H-indole derivatives against methicillin-resistant Staphylococcus aureus.
Al-Qawasmeh RA; Huesca M; Nedunuri V; Peralta R; Wright J; Lee Y; Young A
Bioorg Med Chem Lett; 2010 Jun; 20(12):3518-20. PubMed ID: 20483613
[TBL] [Abstract][Full Text] [Related]
12. Potent antibacterial activity of halogenated compounds against antibiotic-resistant bacteria.
Vairappan CS; Kawamoto T; Miwa H; Suzuki M
Planta Med; 2004 Nov; 70(11):1087-90. PubMed ID: 15549668
[TBL] [Abstract][Full Text] [Related]
13. In vitro antibacterial activity of the peptide PsVP-10 against antimicrobial-resistant Enterococcus faecalis isolated from clinical samples.
Padilla C; Lobos O; Brevis P; Abaca P; Hubert E
J Antimicrob Chemother; 2004 Feb; 53(2):390-2. PubMed ID: 14729763
[TBL] [Abstract][Full Text] [Related]
14. The effects of ultraviolet radiation on antibiotic-resistant bacteria in vitro.
Conner-Kerr TA; Sullivan PK; Gaillard J; Franklin ME; Jones RM
Ostomy Wound Manage; 1998 Oct; 44(10):50-6. PubMed ID: 9866596
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of an environmental strain, Enterococcus faecalis CECT7121, and its effects as additive on craft dry-fermented sausages.
Sparo M; Nuñez GG; Castro M; Calcagno ML; García Allende MA; Ceci M; Najle R; Manghi M
Food Microbiol; 2008 Jun; 25(4):607-15. PubMed ID: 18456116
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections.
Critchley IA; Green LS; Young CL; Bullard JM; Evans RJ; Price M; Jarvis TC; Guiles JW; Janjic N; Ochsner UA
J Antimicrob Chemother; 2009 May; 63(5):954-63. PubMed ID: 19258353
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic activity of the lantibiotic MU1140.
Ghobrial OG; Derendorf H; Hillman JD
Int J Antimicrob Agents; 2009 Jan; 33(1):70-4. PubMed ID: 18835136
[TBL] [Abstract][Full Text] [Related]
19. [In vitro activity of daptomycin against strains isolated from diabetic foot ulcers].
Sotto A; Laouini D; Bouziges N; Jourdan N; Richard JL; Lavigne JP
Pathol Biol (Paris); 2010 Feb; 58(1):73-7. PubMed ID: 19875242
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies.
Krause KM; Barriere SL; Kitt MM; Benton BM
Diagn Microbiol Infect Dis; 2010 Oct; 68(2):181-5. PubMed ID: 20846593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
